BACKGROUND: @entity296 in @entity1252 ( @entity1252 ) may be secondary to @entity296 (i.e. @entity2401 ) or to systemic complications such as @entity101 . Symptomatic left @entity67 is the most common clinical presentation of @entity296 and is potentially life threatening. Identifying the cause is critical as it dictates therapy. METHODS: We present three cases of @entity1002 suggestive of @entity2401 in @entity1252 @entity1 followed in the Lupus Clinic of the Montreal General Hospital over a 5-year period. RESULTS: The most frequent presentation is acute onset of a marked reduction of the left ventricular ejection fraction (LVEF). All @entity1 were treated with cardiac support, @entity229 , and additional immunosuppressive medications. Improvement of symptoms and LVEF was observed in two of three @entity1 . CONCLUSION: @entity2401 is a rare, but life-threatening, manifestation of @entity1252 . With immunosuppressive medications and cardiovascular support, the long-term outcome is usually favorable.

Acute XXXX : Clinical features and outcome.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity296 :: ('MESH:D009202', 'Disease') :: ['cardiomyopathy', 'Cardiomyopathy', 'myocardial inflammation'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity229 :: ('MESH:D011241', 'Chemical') :: ['prednisone'] @entity1252 :: ('MESH:D008180', 'Disease') :: ['SLE', 'systemic lupus erythematosus'] @entity67 :: ('MESH:D018754', 'Disease') :: ['ventricular dysfunction'] @entity2401 :: ('MESH:D009205', 'Disease') :: ['myocarditis', 'Myocarditis'] @entity1002 :: ('MESH:D018487', 'Disease') :: ['left ventricular failure']
@entity2401 :: (MESH:D009205,Disease) :: ['lupus myocarditis']
